Surge Therapeutics
Latest round
- Series B
Last raised
- May 2023
Total raised
- $53M
Investors
- 10
About Surge Therapeutics
Founded in 2021 by Michael Goldberg (CEO), and based in Massachusetts, US, Surge Therapeutics is a biotechnology research platform that is developing a therapeutic medication that helps cancer patients to live longer lives by preventing post-surgical cancer recurrence. The company provides the SURGERx platform, which is intended to increase the efficacy and safety of immunotherapy medication provided to cancer patients following tumor removal surgery. To improve patient survival results, the firm provides an injectable biodegradable hydrogel that allows for the extended, localized release of cancer immunotherapy at the site of surgical tumor removal.
Who invested in Surge Therapeutics
10 investors across 2 rounds
See all investors in Surge Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Surge Therapeutics
Who invested in Surge Therapeutics?
Surge Therapeutics has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Surge Therapeutics raised?
Surge Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Surge Therapeutics last raise money?
Surge Therapeutics's most recent round on record is a Series B, in May 2023.
What does Surge Therapeutics do?
Founded in 2021 by Michael Goldberg (CEO), and based in Massachusetts, US, Surge Therapeutics is a biotechnology research platform that is developing a therapeutic medication that helps cancer patients to live longer lives by preventing post-surgical cancer recurrence.
Where is Surge Therapeutics headquartered?
Surge Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Surge Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Surge Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Surge Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.